We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+7.54%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
AUM
$2.77B
AUM Growth
+$649M
Cap. Flow
+$643M
Cap. Flow %
23.26%
Top 10 Hldgs %
54.12%
Holding
87
New
19
Increased
31
Reduced
6
Closed
15

Sector Composition

Rank Sector Weight
1 Industrials 15.25%
2 Healthcare 14.18%
3 Energy 10.36%
4 Technology 7.21%
5 Consumer Discretionary 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VINC
51
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$8.43M 0.3%
105,350
+26,038
+33% +$3.22M
LYLT
52
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$8.24M 0.3%
498,504
+434,868
+683% +$10.8M
AGRO icon
53
Adecoagro
AGRO
$1.34B
$7.8M 0.28%
645,702
+311,143
+93% +$2.87M
INVZ icon
54
Innoviz Technologies
INVZ
$114M
$7.47M 0.27%
2,062,757
+353,356
+21% +$1.41M
LAUR icon
55
Laureate Education
LAUR
$5.1B
$7.11M 0.26%
+600,272
New +$7.28M
CTMX icon
56
CytomX Therapeutics
CTMX
$760M
$6.42M 0.23%
2,406,449
BTAI icon
57
BioXcel Therapeutics
BTAI
$32.7M
$5.62M 0.2%
+16,783
New +$4.86M
SWIR
58
DELISTED
Sierra Wireless
SWIR
$5.33M 0.19%
295,683
+266,282
+906% +$4.45M
RETA
59
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$4.54M 0.16%
+138,556
New +$4.11M
COOP
60
DELISTED
Mr. Cooper
COOP
$4.51M 0.16%
98,789
-17,900
-15% -$814K
KORE
61
DELISTED
KORE Group Holdings
KORE
$4.27M 0.15%
142,450
+53,249
+60% +$1.49M
LOTZ
62
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$4.11M 0.15%
3,000,000
+1,492,861
+99% +$2.81M
CLBT icon
63
Cellebrite
CLBT
$3.8B
$4.03M 0.15%
+629,020
New +$4.17M
LUCK
64
Lucky Strike Entertainment
LUCK
$937M
$3.41M 0.12%
+320,377
New +$2.96M
NAUT icon
65
Nautilus Biotechnolgy
NAUT
$114M
$3.25M 0.12%
747,607
QSI icon
66
Quantum-Si Incorporated
QSI
$182M
$3.15M 0.11%
672,385
FLNA
67
Filana Therapeutics
FLNA
$45.1M
$2.58M 0.09%
+69,401
New +$2.94M
MRNS
68
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2.28M 0.08%
+243,474
New +$2.42M
TXMD icon
69
TherapeuticsMD
TXMD
$24.1M
$2.03M 0.07%
106,886
VIAO
70
DELISTED
VIA optronics AG American Depositary Shares, each representing one-fifth of an Ordinary Share
VIAO
$2.02M 0.07%
251,855
SIOX
71
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$2.01M 0.07%
3,000,000
SCTL
72
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$1.94M 0.07%
1,076,587
ANIP icon
73
ANI Pharmaceuticals
ANIP
$1.73B
-307,557
Closed -$14.2M
ARRY icon
74
Array Technologies
ARRY
$799M
-2,253,542
Closed -$35.4M
DAL icon
75
Delta Air Lines
DAL
$59.1B
-1,067,696
Closed -$41.7M

Similar funds

Rubric Capital Management (New York)'s Q1 2022 Portfolio in Review

As of Q1 2022, Rubric Capital Management (New York) held 87 positions worth $2.77B, up 31% from $2.12B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Rubric Capital Management (New York) deployed $643M of net new capital in Q1 2022, opening 19 new positions and adding to 31 existing holdings. Its largest new stake was Happen Inc: 2,800,000 shares worth $44.2M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 27% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Hertz, an estimated $15.6M trimmed.

  • Rubric Capital Management (New York)'s largest Q1 2022 buy was Happen Inc: 2,800,000 shares worth $44.2M.
  • Rubric Capital Management (New York) added most to New Fortress Energy in Q1 2022, an estimated $22.1M increase.
  • Rubric Capital Management (New York)'s biggest Q1 2022 reduction was Hertz, cutting an estimated $15.6M.
  • Rubric Capital Management (New York) fully exited Arconic Corporation in Q1 2022, selling an estimated $58.2M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 54% of its $2.77B portfolio in Q1 2022.
  • Rubric Capital Management (New York) opened 19 new positions and closed 15 in Q1 2022.
  • Rubric Capital Management (New York)'s portfolio value rose 31% quarter-over-quarter to $2.77B.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2022, filed 13 May 2022.